Rohto Pharmaceutical Co (JP:4527) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Rohto Pharmaceutical Co. reported a significant decline in profits for the first half of fiscal year 2025, with net income dropping by 22.1% compared to the previous year, despite an 8.8% rise in net sales. The company has also revised its dividend forecast, reflecting cautious optimism for the remainder of the fiscal year.
For further insights into JP:4527 stock, check out TipRanks’ Stock Analysis page.
